Status:
UNKNOWN
Effect of Combination of Non-sLip Element Balloon (NSE) and druG-coated bAlloon (DCB) for In-steNT Restenosis Lesions
Lead Sponsor:
Mitsui Memorial Hospital
Collaborating Sponsors:
Teikyo University
Tokai University
Conditions:
Coronary Restenosis
Eligibility:
All Genders
20-85 years
Phase:
PHASE4
Brief Summary
Use of SeQuent® Please drug coated balloon (DCB) is effective to treat patients with in-stent restenosis (ISR). However, whether the type of pre-dilatation balloon prior to DCB dilatation impacts on c...
Eligibility Criteria
Inclusion
- patients with in-stent restenosis lesions who are planned to be treated with drug coating balloon
Exclusion
- ST elevation myocardial infarction
- stent thrombosis
- severe renal dysfunction (eGFR \<30 ml/min) except dialysis
- pregnancy
- planned surgery within 3 months
- shock vital
Key Trial Info
Start Date :
June 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2019
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT02300454
Start Date
June 1 2015
End Date
April 1 2019
Last Update
March 23 2017
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Tokai University
Isehara, Kanagawa, Japan
2
Mitsui Memorial Hospital
Chiyoda-Ku, Tokyo, Japan